Shanghai Shenqi Pharmaceutical Investment Management Co Ltd
SSE:600613

Watchlist Manager
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd Logo
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd
SSE:600613
Watchlist
Price: 6.23 CNY 1.96% Market Closed
Market Cap: 3.3B CNY

Gross Margin
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd

44.6%
Current
49%
Average
48.6%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
44.6%
=
Gross Profit
840m
/
Revenue
1.9B

Gross Margin Across Competitors

No Stocks Found

Shanghai Shenqi Pharmaceutical Investment Management Co Ltd
Glance View

Market Cap
3.3B CNY
Industry
Pharmaceuticals

Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. engages in the research and development, manufacture, and sale of antitumor, cardiovascular, cold and cough, children medicine, and anti fungi drugs. The company is headquartered in Shanghai, Shanghai and currently employs 1,371 full-time employees. is a China-based company principally engaged in research and development, manufacture and sale of pharmaceuticals. The Company’s products are targeted for the treatment of influenza, cardio cerebrovascular diseases, rheumatoid bone diseases and in the areas of oncology, antifungal, antipyretic and gynaecology. The firm's main products include cantharidin sodium vitamin B6 injection, cantharidin sodium injection and other Chinese patent drug products. The firm distributes its products in domestic market.

Intrinsic Value
5.45 CNY
Overvaluation 13%
Intrinsic Value
Price
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
44.6%
=
Gross Profit
840m
/
Revenue
1.9B
What is the Gross Margin of Shanghai Shenqi Pharmaceutical Investment Management Co Ltd?

Based on Shanghai Shenqi Pharmaceutical Investment Management Co Ltd's most recent financial statements, the company has Gross Margin of 44.6%.

Back to Top